Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Healthcare Stocks on Investors' Radar -- Endo, Teva Pharma, Ionis Pharma, and Universal Health Services

PR Newswire October 19, 2016

Endo to Announce Third Quarter 2016 Financial Results on November 8, 2016

Canada NewsWire October 18, 2016

Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules

PR Newswire September 30, 2016

Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules

Canada NewsWire September 30, 2016

Meeting Market Demand Strategies & Potential Acquisition Scenarios Stimulate Opportunities in These Stocks

PR Newswire September 26, 2016

Watch These 5 Huge Put Purchases In Monday Trade

Benzinga.com  September 26, 2016

Endo Names Paul Campanelli President and Chief Executive Officer

Canada NewsWire September 23, 2016

Endo Names Paul Campanelli President and Chief Executive Officer

PR Newswire September 23, 2016

Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids

Benzinga.com  September 6, 2016

Endo's President and CEO Adopts 10b5-1 Trading Plan

Canada NewsWire August 18, 2016

Endo's President and CEO Adopts 10b5-1 Trading Plan

PR Newswire August 18, 2016

Under Armour trade offers a 5% return in 32 days, or find similar option trades on Endo International, Sears Holdings, Celgene, and Barrick Gold Corporation

PR Newswire August 15, 2016

Endo Announces OPANA® ER Regulatory Update

Canada NewsWire August 12, 2016

Endo Reports Second Quarter 2016 Financial Results

Canada NewsWire August 8, 2016

Endo Announces Appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals

Canada NewsWire August 8, 2016

Endo to Announce Second Quarter 2016 Financial Results on August 8, 2016

PR Newswire Europe Non Regulatory July 18, 2016

Endo Announces Issuance of Vasostrict® Patent

Canada NewsWire June 28, 2016

Endo Announces FDA Advisory Committee Meeting For OPANA® ER

Canada NewsWire June 15, 2016

Endo Announces Local Qualitest Scholarship Program Award Recipients

PR Newswire June 10, 2016

New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain

PR Newswire Europe Non Regulatory June 3, 2016